Filing Details
- Accession Number:
- 0001213900-21-004433
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-26 17:12:48
- Reporting Period:
- 2021-01-04
- Accepted Time:
- 2021-01-26 17:12:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1174940 | Oragenics Inc | OGEN | Pharmaceutical Preparations (2834) | 593410522 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1598384 | Joseph Hernandez | 15 East Putnam Avenue, Suite 363 Greenwich CT 06830 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $.001 Par Value | Disposition | 2021-01-04 | 176,003 | $0.52 | 4,023,997 | No | 4 | S | Direct | |
Common Stock, $.001 Par Value | Disposition | 2021-01-05 | 500,000 | $0.58 | 3,523,997 | No | 4 | S | Direct | |
Common Stock, $.001 Par Value | Disposition | 2021-01-06 | 1,000,000 | $0.60 | 2,523,997 | No | 4 | S | Direct | |
Common Stock, $.001 Par Value | Disposition | 2021-01-07 | 323,997 | $0.84 | 2,200,000 | No | 4 | S | Direct | |
Common Stock, $.001 Par Value | Disposition | 2021-01-11 | 441,929 | $0.77 | 1,758,071 | No | 4 | S | Direct | |
Common Stock, $.001 Par Value | Disposition | 2021-01-12 | 629,707 | $0.73 | 1,128,364 | No | 4 | S | Direct | |
Common Stock, $.001 Par Value | Disposition | 2021-01-13 | 257,510 | $0.80 | 870,854 | No | 4 | S | Direct | |
Common Stock, $.001 Par Value | Disposition | 2021-01-14 | 870,854 | $0.98 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The reporting person sold these shares of common stock on the open market.
- On May 1, 2020, the reporting person received 9,200,000 shares of Oragenics, Inc. through a Stock Purchase Agreement.
- On January 4, 2021, the reporting person sold 176,003 shares on the open market at $0.52 per share, the market price of the common stock on such date, for total proceeds of $91,521.56.
- On January 5, 2021, the reporting person sold 500,000 shares on the open market at $0.5804 per share, the market price of the common stock on such date, for total proceeds of $290,184.58.
- This reflects the weighted average sale price. On January 6, 2021, the reporting person sold a total of 1,000,000 shares for a total of $645,000 on the open market, with the range of prices for such transactions being $0.60 to $0.73 per share. The reporting person has reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
- On January 7, 2021, the reporting person sold 323,997 shares on the open market at $0.84 per share, the market price of the common stock on such date, for total proceeds of $272,157.48.
- On January 11, 2021, the reporting person sold 441,929 shares on the open market at $0.7710 per share, the market price of the common stock on such date, for total proceeds of $340,710.72.
- This reflects the weighted average sale price. On January 11, 2021, the reporting person sold a total of 629,707 shares for a total of $455,441.30 on the open market, with the range of prices for such transactions being $0.7201 to $0.7501 per share. The reporting person has reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
- On January 13, 2021, the reporting person sold 257,510 shares on the open market at $0.8000 per share, the market price of the common stock on such date, for total proceeds of $205,994.44.
- This reflects the weighted average sale price. On January 14, 2021, the reporting person sold a total of 870,854 shares for a total of $859,466.01 on the open market, with the range of prices for such transactions being $0.9602 to $0.1.0068 per share. The reporting person has reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.